CorWave, a company pioneering innovative cardiac assist devices and currently conducting a clinical investigation following the first implantations of its undulating membrane heart pump, announces the ...
Vertex Pharmaceuticals Inc.’s bad news from a phase II pain study and separately on the regulatory front caused shares (NASDAQ:VRTX) to close Aug. 5 at $393.83, ...
Please provide your email address to receive an email when new articles are posted on . There is only one mechanical heart pump available in the U.S. for patients with heart failure requiring left ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results